An acquisition in Hong Kong by the New Frontier Group, an IPO by Sunho Biologics on the HKEX and a $1.5bn investment into Singapore by AstraZeneca, are signs that investments in next generation cancer treatments are increasing in the region.
The $1.6bn fundraise more than doubled the fund’s target size of $750m. The mid-market strategy will focus on the technology, services and healthcare sectors, prioritising India, SE Asia, Japan and Australia.
The Hong Kong hedge fund has taken the difficult decision after 16 years of trading, as the SFC prosecutes the firm, chief investment officer Simon Sandler, and a former trader, for insider trading.
The global private equity firm's fifth Japanese buyout fund is targeting sectors including technology, media, telecoms, retail and healthcare, and is 70% larger than its previous fund.
Following a Rmb300bn lending boost for unfinished flats from the PBOC, BNP Paribas analysts believe a bottom for property prices might be reached in the second half of 2025.
In order to help residents use the currency in Hong Kong, the HKMA has linked the digital currency with the Faster Payment System. In addition, corporate use cases for cross-boundary trade settlement will be explored.
The Voluntary Code of Conduct Working Group (VCWG), sponsored by the SFC, will work with the Secretariat at the International Capital Market Association.
The manufacturing facility, supported by Singapore's Economic Development Board, is for antibody drug conjugates, and will be designed to be "zero carbon" from its first day of operation in 2029.